18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas

European Journal of Clinical Investigation

Volumn 44, Issue 3, 2014, Pages 325-332

  Blanchet, Elise M ^a   Gabriel, Sophie ^b   Martucci, Victoria ^a   Fakhry, Nicolas ^b   Chen, Clara C ^c   Deveze, Arnaud ^d   Millo, Corina ^c   Barlier, Anne ^d   Pertuit, Morgane ^d   Loundou, Anderson ^d   Pacak, Karel ^a   Taïeb, David ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TIMONE HOSPITAL   (France)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Fluorodeoxyglucose; Genetics; Head and neck paraganglioma; Hereditary cancer; PET CT; Radiopharmaceuticals

Indexed keywords

FLUORODEOXYGLUCOSE F 18; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE; MAX PROTEIN, HUMAN; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; RADIOPHARMACEUTICAL AGENT; SDH5 PROTEIN, HUMAN; SDHB PROTEIN, HUMAN; SDHC PROTEIN, HUMAN; SDHD PROTEIN, HUMAN; SUCCINATE DEHYDROGENASE; TMEM127 PROTEIN, HUMAN; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CHILD; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENOTYPE; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAGANGLIOMA; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULMONARY ARTERY; RADIOLOGICAL PROCEDURES; VERY ELDERLY; ADULT; CHEMODECTOMA; COMPUTER ASSISTED TOMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK PARAGANGLIOMA; MIDDLE AGED; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; PET-CT; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; YOUNG ADULT;

FLUORODEOXYGLUCOSE; GENETICS; HEAD AND NECK PARAGANGLIOMA; HEREDITARY CANCER; PET-CT; RADIOPHARMACEUTICALS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; NEOPLASTIC SYNDROMES, HEREDITARY; PARAGANGLIOMA, EXTRA-ADRENAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUCCINATE DEHYDROGENASE; TOMOGRAPHY, X-RAY COMPUTED; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; YOUNG ADULT;

EID: 84893726994     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12239     Document Type: Article

References (18)

1. Lee KY, Oh YW, Noh HJ, Lee YJ, Yong HS, Kang EY, et al. Extraadrenal paragangliomas of the body: imaging features. Am J Roentgenol 2006;187:492-504.
2. Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009;69:3650-6.
3. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacche M, Mori L, et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 2009;94:1541-7.
4. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009;94:2817-27.
5. Jafri M, Whitworth J, Rattenberry E, Vialard L, Kilby G, Kumar AV, et al. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clin Endocrinol 2013;78:898-906.
6. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 2010;11:366-72.
7. Taieb D, Timmers HJ, Hindie E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 2012;39:1977-95.
8. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 2012;104:700-8.
9. King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, Patronas N, et al. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 2011;96:2779-85.
10. Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging 2012;39:1144-53.
11. Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, et al. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. Clin Endocrinol 2013;79:170-7.
12. Taieb D, Varoquaux A, Chen CC, Pacak K. Current and future trends in the anatomical and functional imaging of head and neck paragangliomas. Semin Nucl Med 2013;43:462-73.
13. Sharma P, Thakar A, Suman Kc S, Dhull VS, Singh H, Naswa N, et al. 68 Ga-DOTANOC PET/CT for baseline evaluation of patients with head neck paraganglioma. J Nucl Med 2013;54:841-7.
14. Kroiss A, Putzer D, Frech A, Decristoforo C, Uprimny C, Gasser RW, et al. A retrospective comparison between (68)Ga-DOTA-TOC PET/CT and (18)F-DOPA PET/CT in patients with extra-adrenal paraganglioma. Eur J Nucl Med Mol Imaging 2013;40:1800-8.
15. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the 'Warburg Effect' and a pivotal target for effective therapy. Semin Cancer Biol 2009;19:17-24.
16. Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, Benit P, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 2009;4:e7094.
17. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 2007;48:932-45.
18. Groheux D, Delord M, Rubello D, Colletti PM, Nguyen ML, Hindie E. Variation of liver SUV on (18)FDG-PET/CT studies in women with breast cancer. Clin Nucl Med 2013;38:422-5.